Manufacturing

#ALS #Alzheimer's #Biomarkers #Breast cancer #Cell and gene therapy #Head and neck cancer #Ice Bucket Challenge #Manufacturing #Neurodegenerative disorders #Oncology #Ophthalmology

This week in drug discovery (3-7 October)

News round-up for 3-7 October by DDW Digital Content Editor Diana Spencer This week has brought new trial results and regulatory approvals shedding light and bringing hope into therapy areas of unmet need. The University of Birmingham and… Read More

#News

#Biologics #Cell and gene therapy #Malaria #Manufacturing #Oncology

This week in drug discovery (26-30 September)

This week in drug discovery (26-30 September) News round-up by DDW Editor Reece Armstrong. An interesting week across the board for the pharma sector with the first biologic for severe asthma approved in the EU. Elsewhere researchers have discovered new ways of  identifying cancer cells and a manufacturing system could… Read More

#News

#Contract development and manufacturing organisations #Drug discovery #Manufacturing #Pharmaceuticals

Maximising outsourcing models beyond time and cost

In this listicle, SAMDITech outlines the benefits of outsourcing models in the pharmaceutical industry, looking past perceived costs to the value outsourcing can bring.   Many biotech and pharmaceutical companies now  rely on contract research organisations (CROs) for drug discovery services. CROs offer an established infrastructure to develop, initiate, execute,… Read More

#News

#Cell and gene therapy #Manufacturing

Cell analysis system could streamline gene therapy manufacturing 

PerkinElmer has launched the Cellaca PLX Image Cytometry System, a first-of-its-kind benchtop platform that enables researchers to assess multiple Critical Quality Attributes (CQAs) of cell samples in a single automated workflow, including cell identity, quality and quantity.  The system, designed by the company’s Nexcelom unit, combines best-in-class… Read More

#News

Professor Matt Trau from UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN)
#Bioengineering #Manufacturing #Molecular research #Nanomedicine / nanotechnology

Could this nano chip change the face of manufacturing?

University of Queensland researchers have pioneered a new chemical process to manufacture molecules that are the building blocks for lifesaving medicines, vaccines and energy storage materials. Professor Matt Trau from UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN) has been awarded an ARC Laureate Fellowship worth $2.9 million to further… Read More

#News

#Cell and gene therapy #Covid-19 #Drug discovery #Manufacturing

The challenges and trends of cell & gene therapies 

DDW Editor Reece Armstrong looks at the cell and gene therapy landscape, examining the challenges facing developers and the trends we can expect to see throughout the year.   There’s no doubt that cell and gene therapies present some of the most exciting opportunities for emerging drugs. This area of medicine, which… Read More

#Exclusive Content #Opinion #Trends & Analysis

Applause
#Biotherapeutics #CDMO #Manufacturing

SGS Quay Pharma receives UK enterprise award 

Pharmaceutical contract development and manufacturing organisation (CDMO) SGS Quay Pharma has been recognised with a Queen’s Award in the UK for the strength of its export sales.   The CDMO won a Queen’s Award for Enterprise in the category of International Trade and was recognised for the… Read More

#News

Peptide
#CDMO #Manufacturing #Oligonucleotides

Cell-penetrating peptides as a delivery system for oligonucleotides

CDMO in peptides and oligonucleotides manufacturing, Bachem, has started building a new future for oligonucleotides: solving the industry’s main challenges around capacity, sustainability and cost-effectiveness. Emerging as a new treatment option in rare and orphan disease areas, oligonucleotide therapeutics have matured into a drug class with a broad indication spectrum. Read More

#Exclusive Content #Opinion

#Biomanufacturing #Cell and Gene Therapy Catapult #Cell therapy #Manufacturing

UK consortium looks to advance cell therapy manufacturing  

A new consortium has been launched in the UK to help drive innovation in the manufacturing of personalised cell therapies.  The consortium was launched by the Cell and Gene Therapy Catapult (CGT Catapult) and will be led by advanced therapy medicinal products (ATMP) developer Achilles Therapeutics. The… Read More

#News

#Drug development #Manufacturing

Altasciences continues manufacturing expansion in the US 

Contract research organisation (CRO) Altasciences is expanding its formulation, manufacturing and analytical services in the US as part of a project with the biopharmaceutical company Alladapt Immunotherapeutics.  Altasciences is building dedicated facilities for Alladapt to help with the company’s Phase III and commercial requirements.  … Read More

#News

#Cytiva #Manufacturing

Cytiva to expand US operations  

Life sciences organisation Cytiva has acquired a new facility in Michigan US to help it expand its resins manufacturing operations outside of Sweden.   The company’s new chromatography resins manufacturing site will be based in Muskegon, Michigan and forms part of Cytiva and Pall Corporation’s $1.5 billion capacity expansion investment.  Cytiva… Read More

#Business & Investment #News

#Biomanufacturing #Cell and gene therapy #Manufacturing

Collaboration aims to advance cell and gene therapy manufacturing  

A collaboration between a medical technology company and a non-profit group is aiming to advance the supply chain for cell and gene manufacturing in a bid to tackle scale-up and quality challenges within the sector.  Terumo Blood and Cell Technologies will work with GenCure to extend and… Read More

#News

#Covid-19 #Manufacturing #mRNA

Moderna to set up mRNA vaccine centre in UK 

Pharmaceutical company Moderna is to set-up a manufacturing and research development centre in the UK following an agreement with the government.   The new mRNA Innovation and Technology Centre will develop mRNA vaccines for respiratory diseases including Covid-19 vaccines that can protect against multiple variants. The aim for… Read More

#News

#Biologics / Biotechnology #Manufacturing

BioLamina plans for US expansion  

Biotechnology company BioLamina is targeting a US expansion with plans to open an office in Boston.  The company will open an office in Boston, MA, to help it better support existing and new customers in the US and enable it to collaborate with science hubs in… Read More

#News

#Cell lines #Manufacturing

KBI Biopharma & Selexis open integrated manufacturing facility  

Contract manufacturing organisation (CMO) KBI Biopharma and cell line development company Selexis have opened an integrated facility in Geneva, Switzerland.  The integrated KBI/Selexis state-of-the-art facility builds upon the companies’ existing market foothold by combining best-in-class cell line development (CLD) and expert mammalian cell manufacturing in a single… Read More

#News